Sign in

CIK 0001721484

  • Emerging growth company

Longeveron Inc.

Sign in to watch
Ticker
LGVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472174146
Phone
+1 305-302-7158
Business address
1951 NW 7TH AVENUE, SUITE 520, MIAMI, FL, 33136
Former names
LONGEVERON LLC
  1. 4 Grant or award General Counsel, Secretary acquired 102,000 shares (grant or award)
  2. 4 Grant or award Chief Financial Officer acquired 102,000 shares (grant or award)
  3. 4 Grant or award CTO & SVP of CMC acquired 102,000 shares (grant or award)
  4. 4 Grant or award Director acquired 17,000 shares (grant or award)
  5. 4 Grant or award Chief Executive Officer acquired 180,000 shares (grant or award)
  6. 4 Grant or award Director acquired 17,000 shares (grant or award)
  7. 4 Grant or award Director acquired 17,000 shares (grant or award)
  8. 4 Grant or award Director acquired 17,000 shares (grant or award)
  9. 4 Shares withheld for taxes CTO & SVP of CMC gave up 4,599 shares (to pay taxes)
  10. 4 Shares withheld for taxes Chief Financial Officer gave up 7,431 shares (to pay taxes)
  11. 4 Shares withheld for taxes Chief Executive Officer gave up 13,146 shares (to pay taxes)
  12. 4 Shares withheld for taxes General Counsel, Secretary gave up 1,562 shares (to pay taxes)
  13. 4 Shares withheld for taxes Chief Medical Officer gave up 7,431 shares (to pay taxes)
  14. 4 Derivatives Options or other derivatives
  15. 4 Shares withheld for taxes General Counsel, Secretary gave up 64,158 shares (to pay taxes)
  16. 4/A Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Open-market sale Director sold 21,000 shares at an average $1.27 ($26,750)
  19. 4 Open-market sale Director sold 2,000 shares at $1.32 ($2,640)
  20. 4 Open-market sale Chief Scientific Officer sold 5,250 shares at $1.40 ($7,367)

Page 4 of 13 · 246 filings